Sage Therapeutics, Inc. (SAGE)

NASDAQ: SAGE · IEX Real-Time Price · USD

14.00

+1.05 (8.11%)

At close: Apr 24, 2024, 4:00 PM

14.31

+0.31 (2.21%)

After-hours: Apr 24, 2024, 7:58 PM EDT

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	841	1,299	2,269	2,506	4,502	3,741	4,491	6,183	1,898	1,683	944
Market Cap Growth	-	-42.73%	-9.45%	-44.34%	20.36%	-16.71%	-27.36%	225.80%	12.78%	78.25%	-
Enterprise Value	92	550	1,007	781	2,429	2,767	3,566	5,663	1,500	1,496	816
PE Ratio	-2.40	-2.40	-4.26	-5.47	7.43	-5.50	-12.04	-22.89	-11.94	-17.81	-26.15
PS Ratio	9.73	15.03	295.22	397.27	4.04	544.66	49.75	-	-	-	-
PB Ratio	1.05	1.63	1.81	1.45	2.17	3.96	5.20	13.00	5.15	9.69	7.75
P/FCF Ratio	-2.40	-2.40	-4.92	-6.62	6.78	-7.00	-17.04	-28.02	-15.80	-23.74	-34.74
P/OCF Ratio	-2.40	-2.40	-4.93	-6.63	6.78	-7.08	-17.23	-28.20	-15.99	-23.81	-34.91
EV/Sales Ratio	1.07	6.36	131.08	123.78	2.18	402.89	39.50	-	-	-	-
EV/EBITDA Ratio	-1.02	-1.02	-1.89	-1.72	3.99	-4.08	-9.59	-21.01	-9.45	-15.85	-24.18
EV/EBIT Ratio	-1.02	-1.02	-1.89	-1.71	4.01	-4.07	-9.56	-20.97	-9.43	-15.83	-24.14
EV/FCF Ratio	-1.02	-1.02	-2.19	-2.06	3.66	-5.18	-13.53	-25.67	-12.49	-21.10	-30.04
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.04	-	-	-	-	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.02	-0.04	0.05	-0.05	-	-	-	-	-
Debt / FCF Ratio	-0.01	-0.01	-0.03	-0.05	0.04	-0.07	-	-	-	-	-
Quick Ratio	10.12	10.12	12.97	20.68	31.27	9.01	10.75	10.00	11.32	12.20	16.48
Current Ratio	10.51	10.51	13.47	21.14	31.58	9.23	10.98	10.11	11.45	12.31	16.61
Asset Turnover	0.08	0.08	0.01	0.00	0.95	0.01	0.09	0	0	0	0
Return on Equity (ROE)	-58.00%	-58.00%	-37.00%	-24.40%	56.10%	-59.80%	-37.40%	-86.10%	-47.90%	-54.30%	-83.60%
Return on Assets (ROA)	-52.40%	-52.40%	-34.70%	-23.30%	51.90%	-54.10%	-35.30%	-75.80%	-44.80%	-51.00%	-38.40%
Return on Capital (ROIC)	-72.06%	-72.06%	-43.25%	-26.38%	28.39%	-72.13%	-45.57%	-57.45%	-43.46%	-54.49%	-27.74%
Earnings Yield	-64.35%	-41.67%	-23.48%	-18.27%	13.46%	-18.18%	-8.30%	-4.37%	-8.38%	-5.62%	-3.82%
FCF Yield	-64.31%	-41.64%	-20.32%	-15.11%	14.75%	-14.29%	-5.87%	-3.57%	-6.33%	-4.21%	-2.88%
Buyback Yield / Dilution	-0.89%	-0.89%	-1.08%	-10.69%	-4.27%	-10.22%	-21.01%	-13.80%	-20.57%	-28.76%	-1345.72%
Total Shareholder Return	-0.89%	-0.89%	-1.08%	-10.69%	-4.27%	-10.22%	-21.01%	-13.80%	-20.57%	-28.76%	-1345.72%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).